Credit Suisse’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-79,251
Closed -$800K 3924
2022
Q4
$800K Buy
+79,251
New +$800K ﹤0.01% 2479